CC-122
Showing 1 - 25 of 1,453
Melanoma Trial in Tampa (CC-122, Nivolumab)
Completed
- Melanoma
- CC-122
- Nivolumab
-
Tampa, FloridaH Lee Moffitt Cancer Center and Research Institute
Sep 27, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Lymphoma, Non-Hodgkin Trial in Japan (CC-122)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- CC-122
-
Nagoya-shi, Aichi, Japan
- +3 more
Nov 14, 2022
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in France, Italy, Netherlands (Obinutuzumab, CC-122)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Obinutuzumab
- CC-122
-
Borddeaux Cedex, France
- +9 more
Nov 11, 2022
Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)
Active, not recruiting
- Multiple Myeloma
- +5 more
- CC-122
-
Duarte, California
- +38 more
Aug 18, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (CC-122, Ibrutinib, Obinutuzumab)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- CC-122
- +2 more
-
La Jolla, California
- +23 more
Aug 20, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- JCAR017
- +7 more
-
Duarte, California
- +17 more
Jan 13, 2023
Carcinoma, Hepatocellular Trial in Worldwide (CC-122, Nivolumab)
Diffuse B-Cell Lymphoma Trial in Worldwide (Avadomide (CC-122), Rituximab, Cyclophosphamide 750mg/m2 by IV infusion)
Completed
- Diffuse B-Cell Lymphoma
- Avadomide (CC-122)
- +4 more
-
Washington, District of Columbia
- +14 more
Apr 28, 2021
Clinical Pharmacology, Healthy Male Volunteer Study Trial in Daytona Beach (CC-122)
Completed
- Clinical Pharmacology, Healthy Male Volunteer Study
- CC-122
-
Daytona Beach, FloridaCovance Clinical Development Services
Nov 7, 2019
Healthy Volunteers Trial in Madison (CC-122)
Completed
- Healthy Volunteers
- CC-122
-
Madison, WisconsinCovance Clinical Research Unit Inc
Nov 7, 2019
Healthy Volunteer Trial in Austin (CC-122, Itraconazole, Fluvoxamine)
Completed
- Healthy Volunteer
- CC-122
- +3 more
-
Austin, TexasPPD Phase 1 Clinic
Jan 15, 2019
Pain, Postoperative Trial in Istanbul (Bupivacaine hydrogen chloride (HCl) 0.025 % in 15+15 ML Injection, Bupivacaine HCl 0.025
Completed
- Pain, Postoperative
- Bupivacaine hydrogen chloride (HCl) 0.025 % in 15+15 ML Injection
- +3 more
-
Istanbul, Fatih, TurkeyIstanbul University
Mar 1, 2022
Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)
Recruiting
- Prostate Cancer
- PSMA-Targeted [In-111]-Labeled Trillium Compound
- PTI-122
-
Glen Burnie, Maryland
- +2 more
Mar 21, 2023
Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe Trial in Spain (OST-122, Placebo)
Completed
- Ulcerative Colitis Chronic Moderate
- Ulcerative Colitis Chronic Severe
- OST-122
- Placebo
-
Santiago de Compostela, A Coruña, Spain
- +15 more
Jan 11, 2023
Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)
Recruiting
- Acromioclavicular Joint Dislocation
- K-wire
-
Chon Buri, ThailandQueen Savang Vadhana Memorial Hospital
May 2, 2023
Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)
Not yet recruiting
- Cervical Cancer
- Game Changers for Cervical Cancer Prevention
- (no location specified)
Aug 17, 2023
Renal Insufficiency Trial in Lakewood, Minneapolis (CC-122)
Completed
- Renal Insufficiency
- CC-122
-
Lakewood, Colorado
- +1 more
Apr 24, 2018
Colorectal Cancer Trial (Administration of CC-3)
Not yet recruiting
- Colorectal Cancer
- Administration of CC-3
- (no location specified)
Aug 11, 2023
Respiratory Insufficiency Trial in Glasgow (Fisher and Paykel "HealthCare Airvo™ 3" high flow system, Conventional Oxygen
Not yet recruiting
- Respiratory Insufficiency
- Fisher and Paykel "HealthCare Airvo™ 3" high flow system
- Conventional Oxygen Therapy
-
Glasgow, Scotland, United KingdomDepartment of Critical Care Medicine, Queen Elizabeth University
Jun 12, 2023
Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)
Not yet recruiting
- Urothelial Bladder Carcinoma
- Sacituzumab govitecan
- +2 more
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Nov 14, 2023